Pfizer said it'll apply to US health regulators on Friday to permit emergency use of its co vid 19 vaccine.

It's the first such application in the US The drug maker and its German partner by on Tech expect to get the blessing of the Food and Drug Administration by mid December.

They say they could immediately ship out the vaccines.

Pfizer aims to have 50 million doses ready this year.

That's enough for the two dose regimen to protect 25 million people.

News of the filing drove shares of Pfizer and Buy on tick higher in early trading Friday.

The application to the FDA comes just days after the two companies reported that their vaccine was 95% effective in preventing COVE in 19 with no major safety concerns.

Thea Click Ation includes safety data on about 100 Children 12 to 15 years old.

Pfizer says nearly half of its US trump participants are between 56 85.

A source tells Reuters.